PMDA — authorised 26 September 2022
- Marketing authorisation holder: NIPPON BOEHRINGER INGELHEIM CO., LTD.
- Status: approved
🇯🇵 Spevigo in Japan
PMDA authorised Spevigo on 26 September 2022
Marketing authorisation
Spevigo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Spevigo approved in Japan?
Yes. PMDA authorised it on 26 September 2022.
Who is the marketing authorisation holder for Spevigo in Japan?
NIPPON BOEHRINGER INGELHEIM CO., LTD. holds the Japanese marketing authorisation.